Articles about Vaccine

A staggering 1.33 crore people registered themselves for the coronavirus vaccine on the Indian government's Co-WIN portal on Wednesday after registrations opened for those aged between 18 and 44 at 4 pm.

Adar Poonawalla, the CEO of the Serum Institute of India (SII), on Wednesday announced that the price of the COVID-19 vaccine Covishield was being reduced from Rs. 400 to Rs. 300 for states.

With just two days to go before COVID-19 vaccination opens for people above 18 years and only two days after Maharashtra administered the highest number of five lakh doses in a day, reports of a shortage of the vaccines poured in from various parts of the state on Wednesday including Mumbai, officials said.

The Supreme Court on Tuesday clarified that the suo motu case on COVID-19 is not meant to supplant the High Courts.

As vaccinations emerge as India's biggest hope against a disastrous second coronavirus wave, a Reuters report has claimed that the federal government, led by Prime Minister Narendra Modi, would not import foreign-made vaccines, but wants states and companies to do so.

The Delhi government on Monday announced that it would provide free COVID-19 vaccines to everyone above the age of 18.

Customs duty and health cess on the import of coronavirus vaccines and medical oxygen have been waived off with immediate effect for a period of three months, the central government said on Saturday.

US agencies are under pressure to take a call on the resumption of the use of Johnson & Johnson's COVID-19 vaccine.

The central government on Wednesday said that a "very small" fraction of people have tested positive for COVID-19 after being vaccinated.

Chhattisgarh Chief Minister Bhupesh Baghel on Wednesday announced that the state government will cover the cost of vaccination against COVID-19 for all people above the age of 18.

Congress leader Rahul Gandhi on Tuesday hit out at the government over its COVID-19 vaccine policy, alleging it is discriminatory and that there is no vaccine guarantee for the weaker sections.

US healthcare giant Johnson & Johnson said on Tuesday that it has sought approval from India's drug regulator to conduct a bridging clinical study of its single-dose COVID-19 vaccine in the country.

Even as several Indian states report a shortage of vaccines, an RTI (Right to Information) query has indicated a huge wastage of doses since the country began its inoculation program this January.

The central government has decided to expand the ongoing COVID-19 vaccination drive to all persons above the age of 18 starting May.

In a major development, New Zealand Cricket (NZC) will provide early vaccinations to the men's team this week.

Karnataka Chief Minister and senior Bharatiya Janata Party (BJP) leader BS Yediyurappa tested positive for coronavirus today. The 78-year-old gave an update about it on Twitter.

As India faces a record surge in coronavirus infections, Serum Institute of India (SII) CEO Adar Poonawalla has raised concerns about the United States and Europe holding back key vaccine raw material.

Earlier this week, India's drug regulator approved Russia's COVID-19 vaccine Sputnik V for restricted use in emergency situations.

Congress leader Rahul Gandhi on Wednesday cited a quote of Mahatma Gandhi to imply that the government's decision to fast-track emergency approval for foreign-produced anti-coronavirus vaccines had been prompted by his party's suggestions.

With a number of states claiming that they are on the verge of running out of vaccines, the Centre on Tuesday said that there is no shortage of doses but planning is a problem.

The United States government recommended a "pause" in the administration of the single-dose Johnson & Johnson (J&J) vaccine amid concerns of a "rare and severe type of blood clot."

The Indian government on Tuesday decided to fast-track the grant of Emergency Use Authorization (EUA) to COVID-19 vaccines that have been approved in other countries.

Sputnik V, the COVID-19 vaccine developed by Russia, was reportedly recommended for Emergency Use Authorization (EUA) in India on Monday.

India is likely to have five more COVID-19 vaccines by October this year, top government sources told the news agency ANI.

A four-day-long Tika Utsav is being organized in India to vaccinate as many eligible people as possible against coronavirus.

The vaccination drive against COVID-19 in Mumbai will take place only in government and civic centers on April 10 and 11 and not in any private hospital, the Brihanmumbai Municipal Corporation (BMC) said on Friday.

Several vaccination centers across Mumbai, including a jumbo COVID-19 facility in business district Bandra Kurla Complex (BKC), suspended inoculation on Friday morning due to a shortage of doses, BMC sources said.

Prime Minister Narendra Modi on Thursday chaired a meeting with Chief Ministers to review the COVID-19 situation in India.

The central government on Wednesday allowed COVID-19 vaccinations at workplaces with 100 eligible and willing beneficiaries.

The central government will now collect data on those testing positive for COVID-19 after getting vaccinated for the viral disease.

Maharashtra, India's worst-hit state in the COVID-19 outbreak, is fast running out of its vaccine stocks, state Health Minister Rajesh Tope said on Wednesday.

The efficacy of the COVID-19 vaccine Covishield could increase to 90% if the two doses are given 2.5-3 months apart, Serum Institute of India CEO Adar Poonawalla said Monday.

India, which is experiencing a sudden rise in the number of COVID-19 cases, is now likely to make available a smaller number of vaccines to the rest of the world, the head of the Global Alliance for Vaccines and Immunization has said.

The central government on Saturday asked states to halt new registrations for COVID-19 vaccinations for healthcare and frontline workers.

As the country is witnessing a surge in coronavirus infections, the central government on Thursday directed all states and union territories to allow COVID-19 vaccination on all days in the month of April.

Odisha registered its highest single-day spike so far this year in coronavirus cases on Wednesday when its tally surged to 3,40,917 after 297 more people tested positive for the infection amidst preparations by the state to inoculate two lakh people from Thursday, a health department official said.

Facing a sudden spike in coronavirus cases, India has halted the export of the AstraZeneca vaccine for now, Reuters reported quoting two sources. Millions of doses of the vaccine are being manufactured by the Pune-based Serum Institute of India (SII), the world's biggest vaccine-maker.

The Serum Institute of India (SII) will reportedly be delaying COVID-19 vaccine supplies to Brazil, Saudi Arabia, and Morocco amid criticism that India is not vaccinating enough people at home.

India has raised the issue of hurdles in the export of raw material for COVID-19 vaccines with the United States.

COVAXIN, the COVID-19 vaccine developed by Hyderabad-based Bharat Biotech, has been found to have 81% interim efficacy against preventing infections, the company said on Wednesday.